Westfield Capital Management CO LP Sarepta Therapeutics, Inc. Transaction History

Westfield Capital Management CO LP

$21.2 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$102.5 - $123.59 $23.6 Million - $28.5 Million	230,618 Added 40.05%	806,400 $97.8 Million
Q2 2023 Aug 11, 2023	SELL	$106.4 - $157.19 $24.1 Million - $35.7 Million	-226,876 Reduced 28.27%	575,782 $65.9 Million
Q1 2023 May 12, 2023	BUY	$117.53 - $155.99 $5.99 Million - $7.95 Million	50,962 Added 6.78%	802,658 $111 Million
Q4 2022 Feb 13, 2023	BUY	$100.86 - $132.13 $15.8 Million - $20.7 Million	156,880 Added 26.37%	751,696 $97.4 Million
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $45 Million - $70.9 Million	594,816 New	594,816 $65.8 Million
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $20.2 Million - $47.2 Million	-279,328 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$125.56 - $178.74 $7.89 Million - $11.2 Million	-62,827 Reduced 18.36%	279,328 $47.6 Million
Q3 2020 Nov 13, 2020	BUY	$127.12 - $172.34 $5.09 Million - $6.9 Million	40,010 Added 13.24%	342,155 $48 Million
Q2 2020 Aug 13, 2020	SELL	$93.0 - $171.7 $4.09 Million - $7.54 Million	-43,941 Reduced 12.7%	302,145 $48.4 Million
Q1 2020 May 14, 2020	BUY	$82.38 - $131.64 $1.63 Million - $2.61 Million	19,808 Added 6.07%	346,086 $33.9 Million
Q4 2019 Feb 13, 2020	BUY	$76.53 - $135.58 $437,522 - $775,110	5,717 Added 1.78%	326,278 $42.1 Million
Q3 2019 Nov 08, 2019	BUY	$72.81 - $156.91 $3.4 Million - $7.33 Million	46,704 Added 17.05%	320,561 $24.1 Million
Q2 2019 Aug 13, 2019	SELL	$112.21 - $151.95 $1.98 Million - $2.68 Million	-17,630 Reduced 6.05%	273,857 $41.6 Million
Q1 2019 May 14, 2019	BUY	$106.67 - $151.68 $3.88 Million - $5.52 Million	36,385 Added 14.26%	291,487 $34.7 Million
Q4 2018 Feb 08, 2019	BUY	$97.32 - $148.76 $15.6 Million - $23.9 Million	160,447 Added 169.51%	255,102 $27.8 Million
Q3 2018 Nov 14, 2018	BUY	$115.31 - $161.51 $10.9 Million - $15.3 Million	94,655 New	94,655 $15.3 Million

Others Institutions Holding SRPT

# of Institutions

529

Shares Held

84.2M

Call Options Held

2.06M

Put Options Held

1.52M

Black Rock Inc. New York, NY

10.3M
Shares

$1.23 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

8.97M
Shares

$1.07 Billion
0.02% of portfolio
Capital International Investors Los Angeles, CA

6.26M
Shares

$745 Million
0.16% of portfolio
Janus Henderson Group PLC London, X0

4.36M
Shares

$519 Million
0.29% of portfolio
State Street Corp Boston, MA

4.27M
Shares

$508 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Westfield Capital Management CO LP with notifications on news.

Account